AOD-9604: hGH Fragment vs GLP-1 Fat-Loss Map

People type AOD-9604 like they found a secret Ozempic in a research vial.

They found a fragment of growth hormone.

AOD-9604 is a 16-amino-acid piece of the C-terminal lipolytic region of human growth hormone. Residues 176-191, with a tyrosine stuck on the front for stability. You will also see Tyr-hGH 177-191. Same idea. Different lock from a GLP-1. Different job from intact hGH.

The class map already lives on peptides for weight loss. This page is the AOD lane. Stay here if you typed the letters and want to know what you are holding. Start on Start Here if fat-loss peptides are not day one.

This is education. It is not medical advice. A research-catalog vial is not a treatment for obesity, diabetes, or “stubborn fat.”

What is AOD-9604?

A peptide is a short chain of amino acids. If you still need that map, read what are peptides first. Insulin is a peptide. Semaglutide is a peptide. AOD-9604 is a peptide. Naming the format does not name the mechanism.

Intact human growth hormone is 191 amino acids. AOD-9604 keeps the lipolytic C-terminal fragment and drops the rest of the hormone’s job description. That design choice is the whole point of the molecule in the literature: chase lipid-metabolism effects without borrowing the full GH / IGF-1 package people worry about when they hear “growth hormone.”

So what is AOD-9604, in the way a beginner should hold it? An hGH fragment aimed at fat metabolism in the papers. Not a gut-hormone agonist. Not a GHRH analog. Not a pen. Not an FDA-approved weight-loss drug.

The hard point: AOD vs GLP-1s vs tesamorelin

You do not need a pharmacology degree. You need three locks and three keys.

Lane	What it actually is	What the evidence is	What it is not
AOD-9604	16-aa lipolytic fragment of hGH (176-191 / Tyr-hGH 177-191).	Mouse lipid-metabolism work. Mixed human weight-loss program data from the Metabolic Pharmaceuticals era. Safety-oriented reviews exist; slam-dunk obesity-drug data does not.	Not a GLP-1. Not intact hGH. Not an FDA-approved obesity drug. Not “Ozempic without the needle.”
GLP-1 / GIP agonists	Engineered gut-hormone receptor drugs (semaglutide, tirzepatide; retatrutide still a trial conversation).	Large randomized obesity trials for the approved products. A clinician and a pharmacy.	Not AOD. Not a research-catalog substitute pen. That map is on the weight-loss hub and the tirzepatide vs semaglutide page.
Tesamorelin	44-aa GHRH analog. Asks the pituitary for a GH pulse.	Egrifta: FDA-approved to reduce excess visceral adipose tissue in adults with HIV-associated lipodystrophy. Visceral fat on imaging, not pinchable hip fat.	Not AOD. Different receptor. Different gland. Full map on tesamorelin.
Intact hGH	191-aa pituitary hormone. Broad anabolic and metabolic effects.	A medical specialty conversation with IGF-1 monitoring when used as a drug.	Not “AOD but better.” A fragment is not a free upgrade sticker on the whole hormone.

You can be interested in all of them. You cannot mash them into one Reddit protocol and call the fragment a clinical result.

What the human data actually says (and does not)

Search volume is not a protocol. Neither is a caption that says “melts fat.”

AOD-9604 was developed as a lipolytic piece of hGH. Preclinical work framed lipid metabolism without the IGF-1 pattern people expect from intact GH. That is interesting. It is also how catalogs ended up stamping “fat burner peptide” on a lyophilized cake.

A 2013 paper by Stier, Vos, and Kenley in the Journal of Endocrinology and Metabolism reviewed the human clinical program. They described AOD9604 as generally well tolerated in the studies they covered, without the IGF-1 pattern you expect from intact hGH. That is a safety story. It is not a slam-dunk obesity-drug story. You can read the paper here.

Metabolic Pharmaceuticals ran the obesity program in the 2000s. AOD-9604 is not an FDA-approved weight-loss drug. WADA lists related GH fragments / AOD-9604 in the prohibited conversation for sport — check the current list if you compete. Mixed human data means mixed. It does not mean “secretly better than tirzepatide if you pin it right.”

If someone tells you AOD-9604 is “the peptide version of a GLP-1,” they are selling. GLP-1s hit gut-hormone receptors that change how hungry you are and how your gut empties. AOD-9604 was built as an hGH fragment aimed at lipid metabolism. Different lock. Different key.

The fragment is real. The design intent is real. Some human program data is real. This page will not crown a caption. If you came here because tens of thousands of people a month type AOD-9604, good. Read the map. Then decide whether this is even the conversation you wanted.

Research catalog vs compounding vs FDA drugs

Three lanes. Keep them.

FDA-approved drugs have an application, a label, an indication, manufacturing the agency inspects for that product. Semaglutide as Ozempic or Wegovy is that lane. Tesamorelin as Egrifta is that lane. AOD-9604 is not. There is no AOD obesity tablet in that drawer.

Compounding is a pharmacy lane. A 503A pharmacy compounds for a patient with a prescription. That lane has its own FDA bulk-substance fights and state-board rules. A compounded AOD prescription, if it exists in a clinic today, is still not an approved obesity drug. It is a different object from a lyophilized research cake with a coupon code.

Research catalogs sell named sequences for research use. COA if you are lucky. “Not for human consumption” on the page. Forums treat that disclaimer as a wink. I do not. A research-use AOD vial is a catalog SKU. It is not a compounding script. It is not a labeled drug. Pretending otherwise is how people get hurt and how this page would get stupid.

I am not going to tell you to buy a research chemical for human use. I am not going to tell you to skip a doctor. I am going to tell you to name the lane before you name the SKU.

How a beginner should think about AOD-9604

Start with the question, not the vial.

Are you trying to change appetite with a prescription incretin drug? That is a clinician visit. Not a reconstitution calculator.

Are you trying to understand a named research fragment because a podcast stacked it next to BPC-157? Read the sequence, the fat-depot claim, and the actual papers. Then decide if it even maps to your goal. Healing peptides are a different file — do not drag oral BPC-157 into a fat-loss stack because the internet likes the letters BPC.

Are you trying to copy Egrifta because an ad said “visceral fat”? That is the tesamorelin conversation, not AOD.

Here is the order I give beginners.

1. Read first. Name the lane before you name the SKU. GLP-1 receptor, hGH fragment, or GHRH analog. Drug, compound, or research catalog.

2. Name the peptide. AOD-9604 is 16 amino acids from the lipolytic end of hGH. If the bottle also says “blend,” read every name on the label.

3. Do not crown the nickname. “Fat burner peptide” won the caption. It did not win a label.

4. If a lyophilized cake is even on the table, learn the reconstitution math. How to reconstitute peptides is the public page for BAC water, U-100 ticks, and not wasting 10% of the vial. I will not dump an AOD protocol next to that math.

A clinician belongs in the loop for anything that sounds like a drug, because some of these molecules are drugs in another bottle, and none of this page is a substitute for that visit.

I am also not going to drop a units-and-days protocol on a public page. That is what Peptides & Pump Pro is for. Ten dollars a month. Seven-day trial. This page is here so you understand the search before you spend money.

Where to get AOD-9604

Education first. You already got the map. This block is the labs I will put my name on, with the codes that fire. Research-use catalog pages. Not a treatment claim. Not a “buy this to treat obesity.”

Limitless is the primary partner on this page for named AOD-9604 vials. BioLongevity does not list AOD, so you will see their shop home (code LEE15) rather than a product card.

AOD-9604 research vials

Limitless AOD-9604 · LEE20Paramount AOD-9604 6 mg · LEE10Peptira AOD-9604 · LEEBioLongevity home · LEE15

S1 sometimes lists AOD with solution — check their shop with code LEE10 if you want to browse that catalog.

Match the product to the job. Do not collect bottles. Do not use a research catalog as a back door to an obesity diagnosis. Paramount’s printed code is LEE10.

Frequently asked questions about AOD-9604

Is AOD-9604 a GLP-1?

No. AOD-9604 is an hGH 176-191 lipolytic fragment. GLP-1 receptor agonists are engineered gut-hormone drugs. Different receptor. Different evidence file. If you wanted the pen conversation, that is the weight-loss hub or tirzepatide vs semaglutide, not this URL.

Is AOD-9604 FDA-approved for weight loss?

No. AOD-9604 is not an FDA-approved drug to treat obesity, diabetes, or “stubborn fat.” Mixed human program data is not a label. A research-catalog vial inherits neither an indication nor a manufacturing license for human use.

Can AOD-9604 replace a GLP-1?

No. Different receptors. Different jobs. Different evidence piles. If a GLP-1 is medically appropriate, that is a prescription conversation with a qualified professional. AOD-9604 is not a loophole around a drug label, a side-effect profile, or a diagnosis.

Is AOD-9604 the same as tesamorelin?

No. Tesamorelin is a GHRH analog with an Egrifta visceral-fat indication in HIV-associated lipodystrophy. AOD is an hGH fragment. Same neighborhood of “fat talk” on forums. Different molecules.

Can I just run an AOD protocol from a forum?

You can do a lot of unwise things. I would not. Name the fragment. Name whether you are holding a research catalog, a compounded script, or a fantasy. Protocol depth lives in Pro on purpose. This public page is the map, not the marching orders.

The bottom line

AOD-9604 is a 16-amino-acid lipolytic fragment of human growth hormone. The AOD people search. A real sequence, a real design intent, mixed human data, and no FDA-approved obesity drug in the rear-view.

It is not a GLP-1. It is not tesamorelin. It is not intact hGH. The class map for fat-loss peptides lives on the weight-loss hub. Labeled incretin talk lives on tirzepatide vs semaglutide. This URL exists because people type the letters.

Keep the lanes. Read the papers. Do not buy a 16-residue cake because a caption told you it was a secret pen.

Read next: peptides for weight loss for the class map, tirzepatide vs semaglutide for dual agonist vs GLP-1, and tesamorelin when the word people meant was visceral fat.

I built Peptides & Pump so you can get this without a guru tax. If you want the protocol library, member discussions, and a place to think out loud before you spend money, that is Pro. If you are not ready to pay, use the free Knowledge Base first. Then come back and argue with me when you have read more than a caption.

---

Supplier footnote: Research suppliers for AOD-9604: Limitless AOD-9604 (code LEE20), Paramount AOD-9604 6 mg (code LEE10), and Peptira AOD-9604 (code LEE). S1 shop home: LEE10. BioLongevity home: LEE15. Match the product to the job. Do not collect bottles.

Disclaimer. This article is for educational and research purposes only. It is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. AOD-9604 is not an FDA-approved drug for obesity, weight loss, diabetes, or any other indication. Research peptides discussed here are research sequences; a research-catalog vial is not a compounded prescription and is not a labeled drug. Most of the published evidence discussed here includes preclinical work and mixed human program data; neither is a substitute for a clinician. Individual results vary. Always consult a qualified healthcare provider before starting any peptide, drug, supplement, or protocol, especially if you have a medical condition or take prescription medication. Peptides & Pump does not sell peptides.

Affiliate disclosure. Some links on this page are affiliate links. If you buy through them, I may earn a commission at no extra cost to you. Codes LEE15, LEE20, LEE, LEE10 (S1), and LEE10 (Paramount) are the ones I actually use where a coupon fires. That commission is how I keep publishing free education. I only link suppliers I am willing to put my name on.